Until we are able to reliably simulate cells, organs, and entire human bodies in silico, we will not be able to move the needle too much on drug design from an AI stand-point (IMO). Like others pointed out, the massive bottle neck in time and cost in getting a drug to market are far removed from developing drug candidates.